Healthcare provider profile · identity verified

Michael S. Weizman, MD

Family Practice · ASHEVILLE, NC · NPI 1366409989

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	291	80
Levothyroxine Sodium	Levothyroxine Sodium	257	69
Simvastatin	Simvastatin	251	69
Losartan Potassium	Losartan Potassium	248	62
Lisinopril	Lisinopril	208	60
Trazodone Hcl	Trazodone Hcl	192	38
Metoprolol Succinate	Metoprolol Succinate	191	55
Gabapentin	Gabapentin	179	46
Amlodipine Besylate	Amlodipine Besylate	178	55
Hydrochlorothiazide	Hydrochlorothiazide	169	46
Lorazepam	Lorazepam	148	23
Omeprazole	Omeprazole	140	33
Tamsulosin Hcl	Tamsulosin Hcl	122	30
Famotidine	Famotidine	121	27
Metformin Hcl Er	Metformin Hcl	117	36
Tramadol Hcl	Tramadol Hcl	116	21
Metformin Hcl	Metformin Hcl	113	29
Rosuvastatin Calcium	Rosuvastatin Calcium	112	28
Clonazepam	Clonazepam	93	17
Allopurinol	Allopurinol	91	22
Albuterol Sulfate Hfa	Albuterol Sulfate	85	25
Synthroid	Levothyroxine Sodium	85	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	82	22
Alendronate Sodium	Alendronate Sodium	81	17
Pantoprazole Sodium	Pantoprazole Sodium	80	23
Alprazolam	Alprazolam	77	22
Citalopram Hbr	Citalopram Hydrobromide	74	21
Prednisone	Prednisone	73	49
Xarelto	Rivaroxaban	73	18
Duloxetine Hcl	Duloxetine Hcl	72	20
Escitalopram Oxalate	Escitalopram Oxalate	72	16
Fenofibrate	Fenofibrate	71	18
Sertraline Hcl	Sertraline Hcl	69	20
Buspirone Hcl	Buspirone Hcl	67	12
Finasteride	Finasteride	64	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	19
Furosemide	Furosemide	61	24
Tizanidine Hcl	Tizanidine Hcl	60	17
Bupropion Hcl Sr	Bupropion Hcl	56	15
Celecoxib	Celecoxib	56	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	20
Fluticasone Propionate	Fluticasone Propionate	56	22
Trulicity	Dulaglutide	56	11
Bupropion Xl	Bupropion Hcl	55	13
Metoprolol Tartrate	Metoprolol Tartrate	55	15
Glimepiride	Glimepiride	54	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	14
Ozempic	Semaglutide	48	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	47	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	47	14
Clonidine Hcl	Clonidine Hcl	45	suppressed
Meloxicam	Meloxicam	42	suppressed
Spironolactone	Spironolactone	42	12
Jardiance	Empagliflozin	39	suppressed
Mirtazapine	Mirtazapine	39	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	37	suppressed
Eliquis	Apixaban	35	suppressed
Pregabalin	Pregabalin	35	11
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	suppressed
Ibuprofen	Ibuprofen	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	suppressed
Meclizine Hcl	Meclizine Hcl	29	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Acyclovir	Acyclovir	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Eszopiclone	Eszopiclone	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Azithromycin	Azithromycin	22	22
Carvedilol	Carvedilol	22	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Fluconazole	Fluconazole	22	12
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Nystatin	Nystatin	20	14
Diazepam	Diazepam	18	suppressed
Temazepam	Temazepam	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	14
Memantine Hcl	Memantine Hcl	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	15
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Mupirocin	Mupirocin	15	14
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Valsartan	Valsartan	14	suppressed
Alprazolam Er	Alprazolam	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Victoza 3-Pak	Liraglutide	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Estradiol	Estradiol	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error